W. Taylor Kimberly, M.D., Ph.D.

Chief, Division of Neurocritical Care
Neurology, Massachusetts General Hospital
Physician Investigator (Cl)
Center for Genomic Medicine, Mass General Research Institute
Associate Professor of Neurology
Harvard Medical School
Associate Neurologist
Neurology, Massachusetts General Hospital
MD 2004
MSc 2012
amino acids, branched-chain; amyloid beta-protein precursor; amyloid precursor protein secretases; aspartic acid endopeptidases; brain edema; brain ischemia; cerebral infarction; critical care; critical illness; endopeptidases; glyburide; hypoglycemic agents; intensive care; matrix metalloproteinase 9; membrane proteins; stroke Neurological disease takes a unique and tragic toll on our patients. The Kimberly Lab is committed to reducing the devastating effects of acute brain injury by focusing on translational studies that bridge basic science and clinical research. We believe that therapeutic discovery is not a linear path from fundamental mechanism to new drug, but instead a cycle that requires bi-directional and multidisciplinary integration of basic and patient-oriented research. A presence at each stage of discovery—both directly and through strategic collaboration—is central to our mission to advancing new treatments. Consequently, our laboratory is highly multidisciplinary and collaborative, and our work could not be accomplished without our collaborative partners.
Research lab website Publications Clinical Profile
Center for Genomic Medicine
Simches Building
185 Cambridge Street
Boston, MA 02114-2790